Chong Li

765 total citations
44 papers, 419 citations indexed

About

Chong Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Chong Li has authored 44 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Chong Li's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chong Li is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chong Li collaborates with scholars based in China, United States and Australia. Chong Li's co-authors include Bin Xu, Yava Jones‐Hall, Wanqing Liu, Rongrong Wei, Xian Zhang, Peng Tang, Xiaoqing Li, Chen Hou, Rui Li and Imre Noth and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Chong Li

40 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong Li China 11 211 116 83 53 46 44 419
Manabu Nagata Japan 11 107 0.5× 60 0.5× 124 1.5× 36 0.7× 31 0.7× 31 399
Vikas Malhotra India 8 153 0.7× 109 0.9× 161 1.9× 19 0.4× 32 0.7× 32 548
Yinan Zhang United States 13 85 0.4× 211 1.8× 113 1.4× 35 0.7× 63 1.4× 29 629
Niamh Bermingham Ireland 10 46 0.2× 139 1.2× 88 1.1× 30 0.6× 34 0.7× 25 425
Ananya Chakraborty United States 10 131 0.6× 33 0.3× 83 1.0× 61 1.2× 48 1.0× 14 347
Tian Wang China 12 78 0.4× 52 0.4× 83 1.0× 20 0.4× 42 0.9× 43 388
Christine Lin United States 11 75 0.4× 67 0.6× 52 0.6× 80 1.5× 40 0.9× 19 323
Malin E. Winerdal Sweden 11 114 0.5× 167 1.4× 147 1.8× 46 0.9× 44 1.0× 15 660
Zhaoqi Zhang China 13 145 0.7× 41 0.4× 157 1.9× 113 2.1× 15 0.3× 35 562
Bengü Çobanoğlu Türkiye 12 81 0.4× 50 0.4× 96 1.2× 100 1.9× 36 0.8× 57 432

Countries citing papers authored by Chong Li

Since Specialization
Citations

This map shows the geographic impact of Chong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Li more than expected).

Fields of papers citing papers by Chong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Li. The network helps show where Chong Li may publish in the future.

Co-authorship network of co-authors of Chong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Li. A scholar is included among the top collaborators of Chong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Li. Chong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Yu, Dongmei Zhang, Du Chen, et al.. (2025). Molecular Epidemiological Characteristics of blaIMP-4-Carrying Klebsiella pneumoniae ST-11 in Hospitalized Patients. Infection and Drug Resistance. Volume 18. 171–184. 1 indexed citations
2.
Cheng, Ying, Jie Wang, Yan Yu, et al.. (2025). Phase I/II Study of Tifcemalimab, an Anti–B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer. Clinical Cancer Research. 31(14). 2926–2934. 1 indexed citations
3.
Chen, Miaomiao, Wenjian Chen, Hongyu Xu, et al.. (2024). CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells. Journal of Advanced Research. 73. 357–373. 5 indexed citations
4.
Hu, Song, et al.. (2024). A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer. Frontiers in Oncology. 14. 1314301–1314301. 2 indexed citations
5.
6.
7.
Liu, Hui, Lin Zhou, Bin Xu, et al.. (2023). Depression with obstructive sleep apnea lead to high cardiovascular disease morbidity/all‐cause mortality: Findings from the SHHS cohort. Journal of Sleep Research. 32(4). e13828–e13828. 4 indexed citations
8.
Li, Chong, Sisi Liu, Wanxiangfu Tang, et al.. (2022). Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. Journal of Oncology. 2022. 1–10. 3 indexed citations
9.
Lü, Ke, et al.. (2022). Association between vitamin D and zoledronate-induced acute-phase response fever risk in osteoporotic patients. Frontiers in Endocrinology. 13. 991913–991913. 6 indexed citations
10.
Zhang, Ming, et al.. (2021). Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice. BMC Pulmonary Medicine. 21(1). 31–31. 13 indexed citations
11.
Zhao, Lihua, Wei Mai, Jiahui Su, et al.. (2021). A Pilot Study on the Cutoff Value of Related Brain Metabolite in Chinese Elderly Patients With Mild Cognitive Impairment Using MRS. Frontiers in Aging Neuroscience. 13. 617611–617611. 9 indexed citations
12.
Zhang, Xian, et al.. (2020). Prognostic value of visceral pleural invasion in the stage pT1-2N2M0 non-small cell lung cancer: A study based on the SEER registry. Current Problems in Cancer. 45(1). 100640–100640. 10 indexed citations
13.
Hu, Song, et al.. (2019). Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database. Journal of Cancer Research and Clinical Oncology. 145(9). 2397–2404. 10 indexed citations
14.
15.
Dong, Yan, et al.. (2014). Decreased Expression of C10orf10 and Its Prognostic Significance in Human Breast Cancer. PLoS ONE. 9(6). e99730–e99730. 4 indexed citations
16.
Tang, Peng, et al.. (2014). Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease. Oxidative Medicine and Cellular Longevity. 2014. 1–4. 56 indexed citations
17.
Li, Chong, Rongrong Wei, Yava Jones‐Hall, et al.. (2014). Epidermal Growth Factor Receptor (EGFR) Pathway Genes and Interstitial Lung Disease: An Association Study. Scientific Reports. 4(1). 4893–4893. 21 indexed citations
18.
Wei, Rongrong, Chong Li, Yava Jones‐Hall, et al.. (2013). Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. Translational research. 163(5). 494–502. 51 indexed citations
19.
Li, Chong & Jason P. Fine. (2012). Smoothed nonparametric estimation for current status competing risks data. Biometrika. 100(1). 173–187. 5 indexed citations
20.
Li, Maoxing, et al.. (2002). [Studies on chemical constituents of Caesalpinia decapetala (Roth) Alston].. PubMed. 25(11). 794–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manabu Nagata Breakdown of academic impact, for papers by Vikas Malhotra Breakdown of academic impact, for papers by Yinan Zhang Breakdown of academic impact, for papers by Niamh Bermingham Breakdown of academic impact, for papers by Ananya Chakraborty Breakdown of academic impact, for papers by Tian Wang Breakdown of academic impact, for papers by Christine Lin Breakdown of academic impact, for papers by Malin E. Winerdal Breakdown of academic impact, for papers by Zhaoqi Zhang Breakdown of academic impact, for papers by Bengü Çobanoğlu
Rankless by CCL
2026